Literature DB >> 8896481

The costs of managing lower limb-threatening ischaemia.

S Singh1, L Evans, D Datta, P Gaines, J D Beard.   

Abstract

One hundred and fifty consecutive patients presenting with limb-threatening ischaemia were studied prospectively to determine treatment and rehabilitation costs in the first year. Limb salvage was attempted in 104 (69%) patients but failed in 13%. Mortality at 1 year was 27%. The cost of treatment, inpatient stay, occupational therapy, physiotherapy, convalescence, disablement services, home adaptations, home care, district nursing, transportation and outpatient visits were determined for each patient. The patients were classified according to their presentation and initial treatment into five groups (number of patients) whose median management costs (interquartile range) for 12 months were: Gp 1 (23 - Revascularisation for acute ischaemia = 3970 pounds (2984-5511) Gp 2 (29) - Angioplasty for critical ischaemia = 6611 pounds (3630-10,200) Gp 3 (52) - Reconstruction for critical ischaemia = 6766 pounds (4337-9677) Gp 4 (34) - Primary amputation = 10,162 pounds (7894-13,026) Gp 5 (12) - Primary bilateral amputations = 13,848 pounds (11,440-18,056) At 1 year, there was no significant difference in the cost of managing a patient with a critically ischaemic limb by angioplasty or surgical reconstruction. The cost of revascularisation for acute ischaemia was comparatively low because these patients required minimal rehabilitation. The median cost of managing a patient following amputation was almost twice that of successful limb salvage justifying an aggressive revascularisation policy. However, justification of such a policy on economic grounds requires salvage failure episode to be minimised as they increase costs considerably.

Entities:  

Mesh:

Year:  1996        PMID: 8896481     DOI: 10.1016/s1078-5884(96)80257-7

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  9 in total

1.  Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.

Authors:  Michael P Murphy; Jeffrey H Lawson; Brian M Rapp; Michael C Dalsing; Janet Klein; Michael G Wilson; Gary D Hutchins; Keith L March
Journal:  J Vasc Surg       Date:  2011-04-22       Impact factor: 4.268

Review 2.  Cost-effectiveness analysis of drug-coated therapies in the superficial femoral artery.

Authors:  Natalie D Sridharan; Aureline Boitet; Kenneth Smith; Kathy Noorbakhsh; Efthymios Avgerinos; Mohammad H Eslami; Michel Makaroun; Rabih Chaer
Journal:  J Vasc Surg       Date:  2017-09-27       Impact factor: 4.268

3.  A national and single institutional experience in the contemporary treatment of acute lower extremity ischemia.

Authors:  Jonathan L Eliason; Reid M Wainess; Mary C Proctor; Justin B Dimick; John A Cowan; Gilbert R Upchurch; James C Stanley; Peter K Henke
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

Review 4.  Criticial limb ischemia: epidemiology.

Authors:  Mark G Davies
Journal:  Methodist Debakey Cardiovasc J       Date:  2012 Oct-Dec

Review 5.  Cost-effectiveness of medical, endovascular and surgical management of peripheral vascular disease.

Authors:  Zaher Fanari; William S Weintraub
Journal:  Cardiovasc Revasc Med       Date:  2015-07-09

6.  Calcanisation of tibia using Ilizarov fixator in crush injuries of hindfoot: a new method.

Authors:  Mussa Wardak; Emal Wardak; Akshay Goel
Journal:  Int Orthop       Date:  2007-07-17       Impact factor: 3.075

7.  Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial.

Authors:  Matthew T Menard; Alik Farber; Susan F Assmann; Niteesh K Choudhry; Michael S Conte; Mark A Creager; Michael D Dake; Michael R Jaff; John A Kaufman; Richard J Powell; Diane M Reid; Flora Sandra Siami; George Sopko; Christopher J White; Kenneth Rosenfield
Journal:  J Am Heart Assoc       Date:  2016-07-08       Impact factor: 5.501

8.  Analysis of the Peri-Operative Cost of Non-Traumatic Major Lower Extremity Amputation in Jordan.

Authors:  Qusai Aljarrah; Sohail Bakkar; Abdelwahab Aleshawi; Omar Al-Gharaibeh; Mooath Al-Jarrah; Radi Ebwayne; Mohammed Allouh; Ahmad K Abou-Foul
Journal:  Clinicoecon Outcomes Res       Date:  2020-01-09

9.  TRICKS magnetic resonance angiography at 3-tesla for assessing whole lower extremity vascular tree in patients with high-grade critical limb ischemia: DSA and TASC II guidelines correlations.

Authors:  Sheung-Fat Ko; Jiunn-Jye Sheu; Chen-Chang Lee; Chung-Cheng Huang; Fan-Yen Lee; Shu-Hang Ng; Yi-Wei Lee; Hon-Kan Yip; Min-Chi Chen
Journal:  ScientificWorldJournal       Date:  2012-12-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.